Modeling the functional genomics of autism using human neurons

Molecular Psychiatry

Volumn 17, Issue 2, 2012, Pages 202-214

  Konopka, G ^a,b   Wexler, E ^a,b   Rosen, E ^a,b   Mukamel, Z ^a,b   Osborn, G E ^a,b   Chen, L ^a,b   Lu, D ^a,b   Gao, F ^a,b   Gao, K ^a,b   Lowe, J K ^a,b   Geschwind, D H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

high throughput drug screen; model system; neurodevelopment; neuropsychiatric disease; pharmacogenomics

Indexed keywords

NEUREXIN;

ARTICLE; AUTISM; CELL CULTURE; CONTROLLED STUDY; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MITOSIS; NERVE CELL; NERVE CELL DIFFERENTIATION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

AUTISTIC DISORDER; CELL DIFFERENTIATION; CELLS, CULTURED; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENOMICS; GENOTYPE; GESTATIONAL AGE; HUMANS; KI-67 ANTIGEN; MODELS, GENETIC; NERVE TISSUE PROTEINS; NEURAL STEM CELLS; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS;

EID: 84856218706     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2011.60     Document Type: Article

References (80)

1. Bucan M, Abrahams BS, Wang K, Glessner JT, Herman EI, Sonnenblick LI et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet 2009; 5: e1000536.
2. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 2009; 459: 569-573.
3. Ma D, Salyakina D, Jaworski JM, Konidari I, Whitehead PL, Andersen AN et al. A genome-wide association study of autism reveals a common novel risk locus at 5p14.1. Ann Hum Genet 2009; 73(Part 3): 263-273.
4. Pinto D, Pagnamenta AT, Klei L, Anney R, Merico D, Regan R et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010; 466: 368-372.
5. Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T et al. Strong association of de novo copy number mutations with autism. Science 2007; 316: 445-449. (Pubitemid 46651493)
6. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009; 459: 528-533.
7. Weiss LA, Arking DE, Daly MJ, Chakravarti A. A genome-wide linkage and association scan reveals novel loci for autism. Nature 2009; 461: 802-808.
8. Bill BR, Geschwind DH. Genetic advances in autism: heterogeneity and convergence on shared pathways. Curr Opin Genet Dev 2009; 19: 271-278.
9. Silverman JL, Yang M, Lord C, Crawley JN. Behavioural phenotyping assays for mouse models of autism. Nat Rev Neurosci 2010; 11: 490-502.
10. Nakatani J, Tamada K, Hatanaka F, Ise S, Ohta H, Inoue K et al. Abnormal behavior in a chromosome-engineered mouse model for human 15q11-13 duplication seen in autism. Cell 2009; 137: 1235-1246.
11. Flint J, Shifman S. Animal models of psychiatric disease. Curr Opin Genet Dev 2008; 18: 235-240.
12. Kabashi E, Champagne N, Brustein E, Drapeau P. In the swim of things: recent insights to neurogenetic disorders from zebrafish. Trends Genet 2010; 26: 373-381.
13. Miller JA, Horvath S, Geschwind DH. Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways. Proc Natl Acad Sci USA 2010; 107: 12698-12703.
14. Konopka G, Bomar JM, Winden K, Coppola G, Jonsson ZO, Gao F et al. Human-specific transcriptional regulation of CNS development genes by FOXP2. Nature 2009; 462: 213-217.
15. Oldham MC, Konopka G, Iwamoto K, Langfelder P, Kato T, Horvath S et al. Functional organization of the transcriptome in human brain. Nat Neurosci 2008; 11: 1271-1282.
16. Plaisier CL, Horvath S, Huertas-Vazquez A, Cruz-Bautista I, Herrera MF, Tusie-Luna T et al. A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia. PLoS Genet 2009; 5: e1000642.
17. Winden KD, Oldham MC, Mirnics K, Ebert PJ, Swan CH, Levitt P et al. The organization of the transcriptional network in specific neuronal classes. Mol Syst Biol 2009; 5: 291.
18. Horvath S, Dong J. Geometric interpretation of gene coexpression network analysis. PLoS Comput Biol 2008; 4: e1000117.
19. Chen Y, Zhu J, Lum PY, Yang X, Pinto S, MacNeil DJ et al. Variations in DNA elucidate molecular networks that cause disease. Nature 2008; 452: 429-435. (Pubitemid 351450844)
20. Horvath S, Zhang B, Carlson M, Lu KV, Zhu S, Felciano RM et al. Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci USA 2006; 103: 17402-17407. (Pubitemid 44788981)
21. Stadtfeld M, Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev 2010; 24: 2239-2263.
22. Marchetto MC, Carromeu C, Acab A, Yu D, Yeo GW, Mu Y et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010; 143: 527-539.
23. Hu BY,Weick JP, Yu J,Ma LX, Zhang XQ, Thomson JA et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010; 107: 4335-4340.
24. Bauman ML, Kemper TL. Neuroanatomic observations of the brain in autism: a review and future directions. Int J Dev Neurosci 2005; 23: 183-187. (Pubitemid 40313551)
25. Geschwind DH, Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 2007; 17: 103-111. (Pubitemid 46237744)
26. Pardo CA, Eberhart CG. The neurobiology of autism. Brain Pathol 2007; 17: 434-447. (Pubitemid 47537607)
27. Wexler EM, Paucer A, Kornblum HI, Palmer TD, Geschwind DH. Endogenous Wnt signaling maintains neural progenitor cell potency. Stem Cells 2009; 27: 1130-1141.
28. Svendsen CN, ter Borg MG, Armstrong RJ, Rosser AE, Chandran S, Ostenfeld T et al. A new method for the rapid and long term growth of human neural precursor cells. J Neurosci Methods 1998; 85: 141-152. (Pubitemid 29003064)
29. Palmer TD, Schwartz PH, Taupin P, Kaspar B, Stein SA, Gage FH. Cell culture. Progenitor cells from human brain after death. Nature 2001; 411: 42-43. (Pubitemid 32428181)
30. Esquenet M, Swinnen JV, Heyns W, Verhoeven G. LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids. J Steroid Biochem Mol Biol 1997; 62: 391-399. (Pubitemid 28012866)
31. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575. (Pubitemid 47330214)
32. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF et al. PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 2007; 17: 1665-1674. (Pubitemid 350074862)
33. Abu-Khalil A, Fu L, Grove EA, Zecevic N, Geschwind DH. Wnt genes define distinct boundaries in the developing human brain: implications for human forebrain patterning. J Comp Neurol 2004; 474: 276-288. (Pubitemid 38702687)
34. Dahlstrand J, Lardelli M, Lendahl U. Nestin mRNA expression correlates with the central nervous system progenitor cell state in many, but not all, regions of developing central nervous system. Brain Res Dev Brain Res 1995; 84: 109-129.
35. Lee MK, Tuttle JB, Rebhun LI, Cleveland DW, Frankfurter A. The expression and posttranslational modification of a neuronspecific beta-tubulin isotype during chick embryogenesis. Cell Motil Cytoskeleton 1990; 17: 118-132. (Pubitemid 20372179)
36. Izant JG, McIntosh JR. Microtubule-associated proteins: a monoclonal antibody to MAP2 binds to differentiated neurons. Proc Natl Acad Sci USA 1980; 77: 4741-4745.
37. Eng LF. Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J Neuroimmunol 1985; 8: 203-214. (Pubitemid 15025252)
38. Scales TM, Lin S, Kraus M, Goold RG, Gordon-Weeks PR. Nonprimed and DYRK1A-primed GSK3 beta-phosphorylation sites on MAP1B regulate microtubule dynamics in growing axons. J Cell Sci 2009; 122(Part 14): 2424-2435.
39. Heins N, Malatesta P, Cecconi F, Nakafuku M, Tucker KL, Hack MA et al. Glial cells generate neurons: the role of the transcription factor Pax6. Nat Neurosci 2002; 5: 308-315. (Pubitemid 34279810)
40. Bailey JA, Lahiri DK. Neuronal differentiation is accompanied by increased levels of SNAP-25 protein in fetal rat primary cortical neurons: implications in neuronal plasticity and Alzheimer's disease. Ann N Y Acad Sci 2006; 1086: 54-65. (Pubitemid 47084369)
41. Flanagan JG, Vanderhaeghen P. The ephrins and Eph receptors in neural development. Annu Rev Neurosci 1998; 21: 309-345. (Pubitemid 28150666)
42. Pasterkamp RJ, Kolodkin AL. Semaphorin junction: making tracks toward neural connectivity. Curr Opin Neurobiol 2003; 13: 79-89. (Pubitemid 36197931)
43. O'Leary DD, Sahara S. Genetic regulation of arealization of the neocortex. Curr Opin Neurobiol 2008; 18: 90-100.
44. Gaspard N, Gaillard A, Vanderhaeghen P. Making cortex in a dish: in vitro corticopoiesis from embryonic stem cells. Cell Cycle 2009; 8: 2491-2496.
45. Johnson MB, Kawasawa YI, Mason CE, Krsnik Z, Coppola G, Bogdanovic D et al. Functional and evolutionary insights into human brain development through global transcriptome analysis. Neuron 2009; 62: 494-509.
46. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008; 9: 341-355. (Pubitemid 351556064)
47. Uemura T, Lee SJ, Yasumura M, Takeuchi T, Yoshida T, Ra M et al. Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum. Cell 2010; 141: 1068-1079.
48. Fairless R, Masius H, Rohlmann A, Heupel K, Ahmad M, Reissner C et al. Polarized targeting of neurexins to synapses is regulated by their C-terminal sequences. J Neurosci 2008; 28: 12969-12981.
49. Geschwind DH, Konopka G. Neuroscience in the era of functional genomics and systems biology. Nature 2009; 461: 908-915.
50. Zhang B, Horvath S. A general framework for weighted gene co-expression network analysis. Stat Appl Genet Mol Biol 2005; 4: Article17.
51. Mars WM, Zarnegar R, Michalopoulos GK. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol 1993; 143: 949-958. (Pubitemid 24058250)
52. Cook Jr EH, Scherer SW. Copy-number variations associated with neuropsychiatric conditions. Nature 2008; 455: 919-923.
53. Crespi B, Badcock C. Psychosis and autism as diametrical disorders of the social brain. Behav Brain Sci 2008; 31: 241-261; discussion 261-320.
54. Crespi B, Stead P, Elliot M. Evolution in health and medicine Sackler colloquium: Comparative genomics of autism and schizophrenia. Proc Natl Acad Sci USA 2009; 107(Suppl 1): 1736-1741.
55. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009; 460: 748-752.
56. Konopka G. Functional genomics of the brain: uncovering networks in the CNS using a systems approach. Wiley Interdiscip Rev Syst Biol Med 2010; 3: doi: 10.1002/wsbm.139.
57. Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F et al. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 2010; 26: 363-372.
58. Scott-Van Zeeland AA, Abrahams BS, Alvarez-Retuerto AI, Sonnenblick LI, Rudie JD, Ghahremani D et al. Altered functional connectivity in frontal lobe circuits is associated with variation in the autism risk gene CNTNAP2. Sci Transl Med 2010; 2: 56ra80.
59. Melillo R, Leisman G. Autistic spectrum disorders as functional disconnection syndrome. Rev Neurosci 2009; 20: 111-131.
60. Betancur C, Sakurai T, Buxbaum JD. The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends Neurosci 2009; 32: 402-412.
61. Sudhof TC. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008; 455: 903-911.
62. Cantor RM, Geschwind DH. Schizophrenia: genome, interrupted. Neuron 2008; 58: 165-167. (Pubitemid 351539012)
63. Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008; 320: 539-543. (Pubitemid 351590668)
64. Noebels JL. The biology of epilepsy genes. Annu Rev Neurosci 2003; 26: 599-625. (Pubitemid 37064945)
65. Spence SJ, Schneider MT. The role of epilepsy and epilepti form EEGs in autism spectrum disorders. Pediatr Res 2009; 65: 599-606.
66. van Bon BWM, Mefford HC, de Vries BBA. 15q13.3 Microdeletion. In: Pagon RA, Bird TD, Dolan CR, Stephens K (eds). GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2010, December 23.
67. Hamdan FF, Daoud H, Piton A, Gauthier J, Dobrzeniecka S, Krebs MO et al. De Novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry 2011; 69: 898-901.
68. Walsh CA, Engle EC. Allelic diversity in human developmental neurogenetics: insights into biology and disease. Neuron 2010; 68: 245-253.
69. Brooks-Kayal A. Epilepsy and autism spectrum disorders: are there common developmental mechanisms? Brain Dev 2010; 32: 731-738.
70. Strauss KA, Puffenberger EG, Huentelman MJ, Gottlieb S, Dobrin SE, Parod JM et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med 2006; 354: 1370-1377.
71. Chu TT, Liu Y. An integrated genomic analysis of gene-function correlation on schizophrenia susceptibility genes. J Hum Genet 2010; 55: 285-292.
72. Lesch KP, Timmesfeld N, Renner TJ, Halperin R, Roser C, Nguyen TT et al. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 2008; 115: 1573-1585.
73. Kim HG, Kishikawa S, Higgins AW, Seong IS, Donovan DJ, Shen Y et al. Disruption of neurexin 1 associated with autism spectrum disorder. Am J Hum Genet 2008; 82: 199-207. (Pubitemid 351735950)
74. Kumar RA, Sudi J, Babatz TD, Brune CW, Oswald D, Yen M et al. A de novo 1p34.2 microdeletion identifies the synaptic vesicle gene RIMS3 as a novel candidate for autism. J Med Genet 2010; 47: 81-90.
75. Garbern JY, Neumann M, Trojanowski JQ, Lee VM, Feldman G, Norris JW et al. A mutation affecting the sodium/proton exchanger, SLC9A6, causes mental retardation with tau deposition. Brain 2010; 133(Part 5): 1391-1402.
76. Egea J, Klein R. Bidirectional Eph-ephrin signaling during axon guidance. Trends Cell Biol 2007; 17: 230-238. (Pubitemid 46679245)
77. Roffers-Agarwal J, Gammill LS. Neuropilin receptors guide distinct phases of sensory and motor neuronal segmentation. Development 2009; 136: 1879-1888.
78. Hilario JD, Rodino-Klapac LR, Wang C, Beattie CE. Semaphorin 5A is a bifunctional axon guidance cue for axial motoneurons in vivo. Dev Biol 2009; 326: 190-200.
79. Sullivan PF. The psychiatric GWAS consortium: big science comes to psychiatry. Neuron 2010; 68: 182-186.
80. Barbaric I, Gokhale PJ, Andrews PW. High-content screening of small compounds on human embryonic stem cells. Biochem Soc Trans 2010; 38: 1046-1050.